It falls under the category of new 3D printing technology by delivering cell materials as the surgeon ‘draws’ a gel ink to fill the damaged bone section. It uses a low powered ultra-violet light that solidifies the ink during administration. Eventually it builds a '3D scaffold' using materials capable of delivering live cells and growth features directly into the injury.
Once cell materials are ‘drawn’ onto the site, they will multiply & turn into functioning nerves, tissue or a muscle.
The overall benefits include giving surgeons more control over where the materials are deposited & reducing overall surgery time. Clinical trials are in the pipeline by researchers in Australia led by Professor Peter Choong, in Melbourne.
Watch this space!
Have you been following this story? What are your thoughts?